Other limitations include unknown group differences in the risk factors of cognitive decline and AD, such as apolipoprotein E ε4 genotypes [46], and inflammation [47], although there were no significant differences between the groups in hypertension, diabetes mellitus, medications, biomarkers of lipid metabolism, physical performance, instrumental ADL functioning, and depressive moods. The gene discussed is APOE; the disease is Alzheimer disease.